PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsObsessive-compulsive disorder
MeSH D009771 - obsessive-compulsive disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001008:Anxiety disorders
$
Success rate
D009771: 
Obsessive-compulsive disorder
$
Success rate
D000067836:Hoarding disorder
0 Companies
0 Drugs
Success rate
D000096705:Excoriation disorder
0 Companies
0 Drugs
Success rate
D014256:Trichotillomania
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieCitalopram Celexa  1998-07-17   
Accord HealthcareFluoxetine Fluoxetine  2020-08-27   
Sertraline Sertraline  2014-11-07   
Ajanta PharmaClomipramine Clomipramine  2020-10-02   
Venlafaxine Venlafaxine  2023-04-12   
Alembic PharmaceuticalsClomipramine Clomipramine  2021-08-04   
Fluoxetine Fluoxetine  2009-03-19   
Venlafaxine Venlafaxine  2010-12-14   
Alkem LaboratoriesVenlafaxine Venlafaxine  2021-06-10   
AllerganFluoxetine Sarafem  2006-05-19   
Clomipramine Clomipramine  1996-11-27   
Fluoxetine Fluoxetine  2002-01-29   
Fluvoxamine Fluvoxamine  2000-12-28   
Paroxetine Paroxetine  2017-06-20   
Almatica PharmaCitalopram Citalopram  2022-01-31   
Sertraline Sertraline  2021-10-04   
Venlafaxine Venlafaxine Besylate 2023-03-27 2022-06-29   
Amneal PharmaceuticalsCitalopram Citalopram  2006-11-30   
Clomipramine Clomipramine  2018-10-31   
Venlafaxine Venlafaxine  2010-05-11   
Anchen PharmaceuticalsVenlafaxine Venlafaxine  2012-03-16   
ANDA RepositorySertraline Sertraline  2007-02-06   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
60%
9/15
Phase 2
29%
12/42
Phase 3
78%
14/18
Approved: 7Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use